
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic impact of genetic alterations and methylation classes in meningioma
Anna S. Berghoff, Thomas Hielscher, Gerda Ricken, et al.
Brain Pathology (2022) Vol. 32, Iss. 2
Open Access | Times Cited: 46
Anna S. Berghoff, Thomas Hielscher, Gerda Ricken, et al.
Brain Pathology (2022) Vol. 32, Iss. 2
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Emerging systemic treatment options in meningioma
Maximilian J. Mair, Anna S. Berghoff, Priscilla K. Brastianos, et al.
Journal of Neuro-Oncology (2022)
Open Access | Times Cited: 41
Maximilian J. Mair, Anna S. Berghoff, Priscilla K. Brastianos, et al.
Journal of Neuro-Oncology (2022)
Open Access | Times Cited: 41
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas
Felix Sahm, Kenneth Aldape, Priscilla K. Brastianos, et al.
Neuro-Oncology (2024) Vol. 27, Iss. 2, pp. 319-330
Open Access | Times Cited: 12
Felix Sahm, Kenneth Aldape, Priscilla K. Brastianos, et al.
Neuro-Oncology (2024) Vol. 27, Iss. 2, pp. 319-330
Open Access | Times Cited: 12
Genomic markers of recurrence risk in atypical meningioma following gross total resection
Rachael A. Vaubel, Rahul Kumar, Taylor M. Weiskittel, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 18
Rachael A. Vaubel, Rahul Kumar, Taylor M. Weiskittel, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 18
EANO guideline on molecular testing of meningiomas for targeted therapy selection
Felix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 6
Felix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 6
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042
Sybren L. N. Maas, Philipp Sievers, Damien C. Weber, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 6, pp. 837-840
Open Access | Times Cited: 14
Sybren L. N. Maas, Philipp Sievers, Damien C. Weber, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 6, pp. 837-840
Open Access | Times Cited: 14
Atypical meningioma: Histopathological, genetic, and epigenetic features to predict recurrence risk.
Elena Marastoni, Valeria Barresi
PubMed (2024) Vol. 39, Iss. 3, pp. 293-302
Closed Access | Times Cited: 4
Elena Marastoni, Valeria Barresi
PubMed (2024) Vol. 39, Iss. 3, pp. 293-302
Closed Access | Times Cited: 4
Ki-67 index as a predictive marker of meningioma recurrence following surgical resection
Mark Mizrachi, Benjamin Hartley, Shahzaib Saleem, et al.
Journal of Clinical Neuroscience (2024) Vol. 124, pp. 15-19
Closed Access | Times Cited: 4
Mark Mizrachi, Benjamin Hartley, Shahzaib Saleem, et al.
Journal of Clinical Neuroscience (2024) Vol. 124, pp. 15-19
Closed Access | Times Cited: 4
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma
Maximilian J. Mair, Sabrina Hartenbach, Erwin Tomasich, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Maximilian J. Mair, Sabrina Hartenbach, Erwin Tomasich, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
DNA methylation meningioma biomarkers: attributes and limitations
Zhaohui Li, Yufei Gao, Jinnan Zhang, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 10
Zhaohui Li, Yufei Gao, Jinnan Zhang, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 10
Molecular landscape of IDH ‐wild type, pTERT ‐wild type adult glioblastomas
Emma Munan Liu, Zhifeng Shi, Kay Ka‐Wai Li, et al.
Brain Pathology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 15
Emma Munan Liu, Zhifeng Shi, Kay Ka‐Wai Li, et al.
Brain Pathology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 15
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial
Maximilian Deng, Sybren L. N. Maas, Felix Hinz, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 4, pp. 701-712
Closed Access | Times Cited: 7
Maximilian Deng, Sybren L. N. Maas, Felix Hinz, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 4, pp. 701-712
Closed Access | Times Cited: 7
Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma
R. K. Joshi, Anuja Sharma, Ritu Kulshreshtha
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200782-200782
Open Access | Times Cited: 2
R. K. Joshi, Anuja Sharma, Ritu Kulshreshtha
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200782-200782
Open Access | Times Cited: 2
The Impact of Molecular and Genetic Analysis on the Treatment of Patients with Atypical Meningiomas
Janez Ravnik, Hojka Rowbottom
Diagnostics (2024) Vol. 14, Iss. 16, pp. 1782-1782
Open Access | Times Cited: 2
Janez Ravnik, Hojka Rowbottom
Diagnostics (2024) Vol. 14, Iss. 16, pp. 1782-1782
Open Access | Times Cited: 2
Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index
Yu Teranishi, Atsushi Okano, Satoru Miyawaki, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Yu Teranishi, Atsushi Okano, Satoru Miyawaki, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
Alessia Pellerino, Francesco Bruno, Rosa Palmiero, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2256-2256
Open Access | Times Cited: 11
Alessia Pellerino, Francesco Bruno, Rosa Palmiero, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2256-2256
Open Access | Times Cited: 11
DNA methylation provides diagnostic value for meningioma recurrence in clinical practice
Erica Shen, Nathan K. Leclair, Kristi Herlth, et al.
Acta Neurochirurgica (2023) Vol. 165, Iss. 5, pp. 1323-1331
Closed Access | Times Cited: 5
Erica Shen, Nathan K. Leclair, Kristi Herlth, et al.
Acta Neurochirurgica (2023) Vol. 165, Iss. 5, pp. 1323-1331
Closed Access | Times Cited: 5
Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
Reem Halabi, Fatima Dakroub, Mohammad Z. Haider, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5339-5339
Open Access | Times Cited: 5
Reem Halabi, Fatima Dakroub, Mohammad Z. Haider, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5339-5339
Open Access | Times Cited: 5
Mutational signature of extracranial meningioma metastases and their respective primary tumors
Annamaria Biczok, Jun Thorsteinsdottir, Philipp Karschnia, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Annamaria Biczok, Jun Thorsteinsdottir, Philipp Karschnia, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Brain Invasion and Trends in Molecular Research on Meningioma
Kyeong-O Go, Young Zoon Kim
Brain Tumor Research and Treatment (2023) Vol. 11, Iss. 1, pp. 47-47
Open Access | Times Cited: 4
Kyeong-O Go, Young Zoon Kim
Brain Tumor Research and Treatment (2023) Vol. 11, Iss. 1, pp. 47-47
Open Access | Times Cited: 4
Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer
Zhen Ye, Guangle Song, Jianwei Liang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Zhen Ye, Guangle Song, Jianwei Liang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo
Yuta Mitobe, Shuhei Suzuki, Yurika Nakagawa-Saito, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1967-1967
Open Access | Times Cited: 4
Yuta Mitobe, Shuhei Suzuki, Yurika Nakagawa-Saito, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1967-1967
Open Access | Times Cited: 4
A Case of Recurrence of Benign Convexity Primary Intraosseous Meningioma
Masahiro Ueno, Shinji Shimato
NMC Case Report Journal (2024) Vol. 11, pp. 19-25
Open Access | Times Cited: 1
Masahiro Ueno, Shinji Shimato
NMC Case Report Journal (2024) Vol. 11, pp. 19-25
Open Access | Times Cited: 1
Meningioma recurrence: Time for an online prediction tool?
Abdulrahman Albakr, Amir Baghdadi, Brij Karmur, et al.
Surgical Neurology International (2024) Vol. 15, pp. 155-155
Open Access | Times Cited: 1
Abdulrahman Albakr, Amir Baghdadi, Brij Karmur, et al.
Surgical Neurology International (2024) Vol. 15, pp. 155-155
Open Access | Times Cited: 1
DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case–Control Study
Matthias Millesi, Alice Senta Ryba, Johannes A. Hainfellner, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Matthias Millesi, Alice Senta Ryba, Johannes A. Hainfellner, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
Nivedha Kannapadi, Pavan P. Shah, Dimitrios Mathios, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Nivedha Kannapadi, Pavan P. Shah, Dimitrios Mathios, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5